NHSA Unveils 2024 Medical Procurement Overhaul, Aiming for Synergy Between National and Provincial Levels
The National Healthcare Security Administration (NHSA) has issued a notification detailing plans to enhance the...
Fineline Cube
BGI Genomics Delays Market Filing for BRCA1/2 Detection Kit Due to Incomplete Data
BGI Genomics Co., Ltd (SHE: 300676), a leading genomics company based in China, has announced...
Hymson Laser’s Mid Infrared Femtosecond Laser Technology Makes Medical Industry Inroads
Shenzhen-based Hymson Laser Technology Group Co., Ltd (SHA: 688559) has announced a significant breakthrough with...
BMS’s Sotyktu Sustains Clinical Response in Long-Term Psoriasis Treatment
Bristol Myers Squibb (BMS; NYSE: BMY) has announced the release of long-term clinical data for...
China and South Korea Reinforce Ties with Renewed MOU on Pharmaceuticals and Cosmetics Regulation
The National Medical Products Administration (NMPA) of China and the Ministry of Food and Drug...
Pharmaron and AstraZeneca Enter Sweeping Partnership to Span Drug Development Services
Pharmaron Beijing Co., Ltd, a leading Contract Research Organization (CRO) based in Beijing (HKG: 3759;...
Jiangsu Hengrui’s SHR1905 Anti-TSLP mAb Gets Green Light for COPD Clinical Trial
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a prominent Chinese pharmaceutical company, announced that it...
Innovent Biologics’ IBI311 New Drug Application Accepted for Review by China’s CDE
Innovent Biologics Inc., (HKG: 1801), a leading biopharmaceutical company in China, has announced that the...
Union Hospital Teams Up with Baidu Health for AI-Enhanced Outpatient Services
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has entered into a...
Zai Lab and Innoviva Win China Approval for SUL-DUR to Treat Hospital-Acquired Pneumonia
Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688), a China-based biopharmaceutical company, in collaboration with US...
FDA Gives Accelerated Nod to Amgen’s Imdelltra in Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has granted accelerated approval to Amgen (NASDAQ: AMGN)...
Eli Lilly’s Weekly Insulin Efsitora Alfa Matches Daily Basal Insulins in Reducing A1C Levels
Eli Lilly and Company (NYSE: LLY), a global healthcare company, has announced results from a...
Pharmaron to Sell Proteologix Stake in Upcoming Johnson & Johnson Acquisition
Pharmaron Beijing Co., Ltd, a leading Contract Research Organization (CRO) based in Beijing (HKG: 3759;...
Fosun Pharma Nods to Fosun Health Spin-Off; IPO Venue and Requirements Under Review
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading pharmaceutical company in...
Medtronic’s Advanced Mazor X Spinal Surgery Robot Receives Chinese Market Clearance
Medtronic (NYSE: MDT), the US-Irish medical technology giant, has announced that it has received approval...
Zhejiang Huahai Pharmaceutical Co., Ltd Plans Capital Raise for Digital Manufacturing Expansion
Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521), a leading Chinese pharmaceutical company, has unveiled plans...
Porton Biologics and SAFE Collaborate to Accelerate Pharmaceutical R&D Services
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
Biotherus Inc. Advances PM8002 Bispecific Antibody to Phase III for Triple Negative Breast Cancer
China’s Biotheus Inc. has announced the initiation of a Phase III clinical study for its...
Jiangsu Hengrui’s Camrelizumab/Apatinib Combo Denied FDA Approval Over Manufacturing Issues
The US Food and Drug Administration (FDA) has issued a complete response letter to Jiangsu...
ImmuneOnco Biopharmaceuticals’ CD47 Inhibitor Receives NMPA Go-Ahead for Phase III Trial
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd has announced that it has received approval from the National...